Our Story
Optimi Health Corp. is an end-to-end Canadian-based drug manufacturer and formulator licensed by Health Canada to produce and supply psychedelic substances such as 3,4-Methylenedioxymethamphetamine (“MDMA”) and natural, GMP-grade psilocybin, as well as functional mushrooms that focus on the health and wellness markets.
Our promise
To make possible a future wherein psychedelic alternatives aid a wide variety of mental health conditions.
Our Goal
To be the number one trusted, compassionate supplier of safe, natural EU-GMP psychedelics in the world.
Our Mission
To grow psychedelic science and medicine as an industry-leading, end-to-end supplier of GMP psychedelic compounds
Exceptional.
People don’t want to just be better — they want to be exceptional. They want to live life at the next level — mentally, emotionally, psychologically, and physically.
Founders Dane Stevens, JJ Wilson, and Bryan & Jacob Safarik started Optimi with a belief that psychedelic medicine and functional mushrooms might improve health and further unlock human potential.
As explorers, innovators, and industry leaders, the Optimi team is continually growing and researching novel, powerful formulations derived from psychedelic compounds.
Through our end-to-end, pharmaceutical-grade GMP manufacturing, cultivation and analytical facilities, Optimi sits at the forefront of a psychedelic revolution poised to profoundly change the way we view ourselves and live our lives.
Welcome to Optimi.
This Is Our Story.
